Iterum Therapeutics PLC (ITRMF) vs NexImmune, Inc. (NEXI)

Iterum Therapeutics PLC and NexImmune, Inc. are both Biotechnology companies. Iterum Therapeutics PLC and NexImmune, Inc. are of similar size ($1.6M and $1.6M). NexImmune, Inc. has the higher net margin (0.00% vs −2,930.5%) and the higher return on invested capital (0.00% vs −455.5%). Across the 11 metrics below, NexImmune, Inc. leads on 6 and Iterum Therapeutics PLC on 5.

Valuation

Metric ITRMF NEXI Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.09 0.74
EV/Sales 24.37 n/m 10.73
Earnings yield 0.00% 0.00% (28.84%)
Free cash flow yield 0.00% 0.00% (23.03%)

Profitability

Metric ITRMF NEXI Biotechnology median
Gross margin (81.85%) 0.00% 65.16%
Operating margin (2,243.48%) 0.00% 0.00%
Net margin (2,930.54%) 0.00% 0.00%
Free cash flow margin (2,122.61%) 0.00% 0.00%
Return on equity 285.48% (232.97%) (57.72%)
Return on assets (111.35%) (140.56%) (49.22%)
Return on invested capital (455.51%) 0.00% 0.00%

Growth

Metric ITRMF NEXI Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 57.43% 52.58% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ITRMF NEXI Biotechnology median
Debt to equity (2.87) 0.00 0.00
Current ratio 2.13 0.66 4.73
Net debt to EBITDA 0.24 0.10 0.96

Dividend

Metric ITRMF NEXI Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ITRMF NEXI Biotechnology median
Market cap 1.59m 1.60m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack